Julia Levy, PhD

Advisory Board

Dr. Julia Levy has served in several key senior posts at QLT, Inc. including Vice President and Chief Scientific Officer as well as President and CEO from 1995 to February 2002. Under her leadership, QLT achieved several major milestones, including FDA approval for Visudyne® therapy to treat age-related blindness in April 2000. A fellow of the Royal Society of Canada, Dr. Levy has earned numerous awards and honors including an appointment as an Officer of the Order of Canada in 2001, Female Entrepreneur of the Year for International Business in 1998, Pacific Canada Entrepreneur of the Year in 2000 and the Lifetime Achievement Award from the British Columbia Biotechnology Association in 2004.  In her honor, the Julia G. Levy Professorship in Ophthalmology Chair was created at Johns Hopkins Hospital Wilmer Eye Institute in 2004.